Simplex Trading, LLC Revance Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 24,378 shares of RVNC stock, worth $62,651. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,378

Previous 58,122 58.06%

Holding current value

$62,651

Previous $149,000 58.39%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$2.57 - $2.57 $86,722 - $86,722	-33,744 Reduced 58.06%	24,378 $62,000
Q2 2024 Jul 25, 2024	BUY	$2.34 - $4.73 $136,005 - $274,917	58,122 New	58,122 $149,000
Q3 2023 Nov 01, 2023	BUY	$11.47 - $25.07 $29,994 - $65,558	2,615 Added 15.98%	18,980 $217,000
Q2 2023 Aug 04, 2023	BUY	$24.7 - $37.61 $19,364 - $29,486	784 Added 5.03%	16,365 $414,000
Q1 2023 Apr 27, 2023	BUY	$18.36 - $35.27 $41,493 - $79,710	2,260 Added 16.97%	15,581 $501,000
Q4 2022 Feb 02, 2023	SELL	$18.32 - $30.66 $628,009 - $1.05 Million	-34,280 Reduced 72.02%	13,321 $245,000
Q3 2022 Nov 04, 2022	BUY	$14.33 - $28.47 $449,603 - $893,246	31,375 Added 193.36%	47,601 $1.29 Million
Q2 2022 Aug 03, 2022	SELL	$11.52 - $20.4 $133,954 - $237,211	-11,628 Reduced 41.75%	16,226 $224,000
Q1 2022 May 02, 2022	BUY	$12.36 - $20.31 $344,275 - $565,714	27,854 New	27,854 $543,000
Q2 2021 Aug 12, 2021	SELL	$26.8 - $31.84 $81,659 - $97,016	-3,047 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$24.03 - $29.97 $85,186 - $106,243	-3,545 Reduced 53.78%	3,047 $85,000
Q4 2020 Feb 02, 2021	SELL	$23.41 - $28.34 $25,704 - $31,117	-1,098 Reduced 14.28%	6,592 $186,000
Q3 2020 Oct 14, 2020	BUY	$23.23 - $34.3 $178,638 - $263,767	7,690 New	7,690 $193,000
Q1 2020 Apr 29, 2020	SELL	$12.46 - $27.81 $109,822 - $245,117	-8,814 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$11.66 - $20.15 $61,821 - $106,835	5,302 Added 150.97%	8,814 $143,000
Q3 2019 Oct 15, 2019	SELL	$10.22 - $14.5 $725 - $1,029	-71 Reduced 1.98%	3,512 $45,000
Q2 2019 Jul 26, 2019	BUY	$10.67 - $15.49 $38,230 - $55,500	3,583 New	3,583 $46,000
Q4 2018 Jan 16, 2019	SELL	$18.06 - $24.96 $34,259 - $47,349	-1,897 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$23.55 - $30.1 $3,626 - $4,635	-154 Reduced 7.51%	1,897 $47,000
Q2 2018 Jul 30, 2018	SELL	$27.45 - $33.35 $7,576 - $9,204	-276 Reduced 11.86%	2,051 $56,000
Q1 2018 Apr 26, 2018	BUY	$29.15 - $37.4 $67,832 - $87,029	2,327 New	2,327 $71,000
Q4 2017 Jan 10, 2018	SELL	$24.55 - $36.3 $111,923 - $165,491	-4,559 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$22.55 - $28.1 $102,805 - $128,107	4,559	4,559 $125,000

Others Institutions Holding RVNC

# of Institutions

232

Shares Held

82.1M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Revance Therapeutics, Inc. Transaction History